Get started
Author

Yuanxiang Lan

Observed names: YUANXIANG LAN, Yuan-xiang Lan
ORCID: 0000-0002-9609-7809
Observed ORCID: 0000-0002-9609-7809
OpenAlex ID: A5100662927
Lycium barbarum glycopeptide alleviates neuroinflammation in spinal cord injury via modulating docosahexaenoic acid to inhibiting MAPKs/NF-kB and pyroptosis pathways
2023 · Zhanfeng Jiang, Zhong Zeng, et al. · Journal of Translational Medicine · 69
Integrated transcriptomic and metabolomic profiling reveals dysregulation of purine metabolism during the acute phase of spinal cord injury in rats
2022 · Zhong Zeng, Mei Li, et al. · Frontiers in Neuroscience · 24
PDF
Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
2023 · Jian Yao, Jian-wen Hui, et al. · Cancer Gene Therapy · 23
PDF
Fabrication of Etoposide-loaded superparamagnetic iron oxide nanoparticles (SPIONs) induced apoptosis in glioma cancer cells
2023 · Zhihua Wang, Ye Wang, et al. · Process Biochemistry · 14
RETRACTED ARTICLE: Circadian Period 2 (Per2) downregulate inhibitor of differentiation 3 (Id3) expression via PTEN/AKT/Smad5 axis to inhibits glioma cell proliferation
2022 · Yifan Zhang, Xvlei Hu, et al. · Bioengineered · 10
Placenta-derived mesenchymal stem cells attenuate secondary brain injury after controlled cortical impact in rats by inhibiting matrix metalloproteinases
2024 · PING YANG, YUANXIANG LAN, et al. · Biocell · 2
PDF
Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
2023 · Jian Yao, Jian-wen Hui, et al. · Cancer Gene Therapy · 2
PDF
Circadian Period 2 (Per2) downregulate inhibitor of differentiation 3 (Id3) expression via PTEN/AKT/Smad5 axis to inhibits glioma cell proliferation
2022 · Yifan Zhang, Xvlei Hu, et al. · Figshare
Works count: 8
Citation count: 144
H-index: 5
I10-index: 5
Year
Topic
Type